Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boogaerts

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Blood|June 15, 1995
Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findingsA Cuneo, A Ferrant, J L Michaux, et al.
Leukemia & Lymphoma|January 1, 1995
Cytogenetics of hybrid acute leukemiasA Cuneo, M Boogaerts, A Ferrant, et al.
Leukemia|March 19, 2004
High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg) treatment in acute myeloid leukemia patientsV H J van der Velden, N Boeckx, I Jedema, et al.
British Journal of Haematology|July 1, 1990
Morphologic, immunologic and cytogenetic studies in erythroleukaemia: evidence for multilineage involvement and identification of two distinct cytogenetic-clinicopathological typesA Cuneo, A Van Orshoven, J L Michaux, et al.
British Journal of Haematology|May 12, 1998
Mobilization of Philadelphia-negative peripheral blood progenitor cells with chemotherapy and rhuG-CSF in chronic myelogenous leukaemia patients with a poor response to interferon-alphaA M Carella, B Simonsson, H Link, et al.
Leukemia|May 1, 1996
Small B cell NHL and their leukemic counterpart: differences in subtyping and assessment of leukemic spreadA Criel, S Pittaluga, G Verhoef, et al.
Annals of Internal Medicine|September 19, 2001
Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trialM Boogaerts, D J Winston, E J Bow, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2001
Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patientsM Boogaerts, J Maertens, A van Hoof, et al.
Blood|June 15, 1996
Differences in the chromosomal profile of AML-M0 versus AML-M1: responseA Cuneo, G Castoldi, J L Michaux, et al.
Haematologica|July 16, 1999
The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factorM F Dresse, M Boogaerts, C Vermylen, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Blood|June 15, 1995
Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findingsA Cuneo, A Ferrant, J L Michaux, et al.
Leukemia & Lymphoma|January 1, 1995
Cytogenetics of hybrid acute leukemiasA Cuneo, M Boogaerts, A Ferrant, et al.
Leukemia|March 19, 2004
High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg) treatment in acute myeloid leukemia patientsV H J van der Velden, N Boeckx, I Jedema, et al.
British Journal of Haematology|July 1, 1990
Morphologic, immunologic and cytogenetic studies in erythroleukaemia: evidence for multilineage involvement and identification of two distinct cytogenetic-clinicopathological typesA Cuneo, A Van Orshoven, J L Michaux, et al.
British Journal of Haematology|May 12, 1998
Mobilization of Philadelphia-negative peripheral blood progenitor cells with chemotherapy and rhuG-CSF in chronic myelogenous leukaemia patients with a poor response to interferon-alphaA M Carella, B Simonsson, H Link, et al.
Leukemia|May 1, 1996
Small B cell NHL and their leukemic counterpart: differences in subtyping and assessment of leukemic spreadA Criel, S Pittaluga, G Verhoef, et al.
Annals of Internal Medicine|September 19, 2001
Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trialM Boogaerts, D J Winston, E J Bow, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2001
Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patientsM Boogaerts, J Maertens, A van Hoof, et al.
Blood|June 15, 1996
Differences in the chromosomal profile of AML-M0 versus AML-M1: responseA Cuneo, G Castoldi, J L Michaux, et al.
Haematologica|July 16, 1999
The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factorM F Dresse, M Boogaerts, C Vermylen, et al.
Pageof 11